Tau phosphorylated at threonine 181 (p‐tau181) is a highly specific biomarker for AD and can detect amyloid and tau even in early symptomatic stages of disease,5, 6, 7 though p‐tau217 has subsequently emerged as having improved diagnostic accuracy.8, 9, 10. Here, MAPT is linked to Alzheimer disease.